Diabetes screening of little benefit

Routinely screening high-risk patients for type 2 diabetes does not save lives, a decade-long study in primary care has found.

Published on Thursday in the Lancet, the research has been described as the “most earnest attempt to date to try and settle the diabetes screening quandary” by the US Centers for Disease Control and Prevention.

The study of more than 16,000 English patients, thought to represent the top 25% of those at risk for undiagnosed diabetes, found rates of death after 10 years were similar in